Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Genitourinary Cancers
Would you offer adjuvant XRT to the prostate fossa in a patient with Lynch Syndrome?
What fields? Would you treat the pelvis? What factors would help you determine this?
Related Questions
Do you dose escalate a patient with high risk prostate cancer who refuses ADT due to potential side effects?
In patients with high risk prostate cancer and involved common iliac lymph nodes would you recommend radiation?
Would you offer prostate SBRT to a patient on a TKI?
What rectal spacer do you recommend for prostate cancer patients?
Would you treat a multifocal clear cell RCC in a solitary kidney with SBRT?
Would you dose escalate for prostate cancer extending to the penile bulb, towards the urethra, and close to anorectal junction?
Why are patients getting enzalutamide s/p prostatectomy not candidates for salvage radiation therapy?
Given results of BCON trial, do you add carbogen and nicotinamide for patients receiving definitive radiotherapy for bladder cancer, particularly for non-cisplatin eligible candidates?
Is there a benefit to sound wave therapy for erectile dysfunction that is due to prostate radiation?
Is there a benefit in proactively referring patients treated with pelvic radiation to see pelvic rehabilitation in the absence of any symptoms?